mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.045 |
0.4 |
mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
0.13 |
0.4 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.4 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |